A rapid and sensitive detection of HPV by combined assay of PCR and fluorescence DNA chip

Biochip Journal

Volumn 8, Issue 1, 2014, Pages 48-54

  Kim, Sung Joong ^a   Nahm, Ki Bong ^b   Lim, Jong Baeck ^c   Oh, Sang Wook ^d   Choi, Eui Yul ^a,b  

^a BodiTech Med Inc   (South Korea)

^b Hallym University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Chonbuk National University   (South Korea)

Author keywords

Capture oligoDNA; DNA chip; Fluorescence detector bead; HPV; PCR

Indexed keywords

ASSAYS; DETECTORS; DNA; ELECTROPHORESIS; FLUORESCENCE; MIXTURES; PROTEINS; SIGNAL DETECTION; VIRUSES;

DNA CHIP; FLUORESCENCE DETECTOR; HPV; OLIGODNA; PCR;

POLYMERASE CHAIN REACTION;

ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; COLPOSCOPY; CROSS HYBRIDIZATION; CROSS REACTION; DNA HYBRIDIZATION; DNA MICROARRAY; FEMALE; GEL ELECTROPHORESIS; GENOTYPE; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; WART VIRUS;

EID: 84897086508     PISSN: 19760280     EISSN: 20927843     Source Type: Journal    
DOI: 10.1007/s13206-014-8108-0     Document Type: Article

References (16)

1. Soeda, E. & Maruyama. T. Molecular evolution in papova viruses and in bacteriophages. Adv. Biophys. 15, 1-17 (1982).
2. Costa, L. J. et al. Human papilloma virus - its association with epithelial proliferative lesions. Braz. Dent. J. 5, 5-10 (1994).
3. zur Hausen, H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer. Inst. 92, 690-698 (2000).
4. Leto, M. G. et al. Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. An Bras Dermatol. 86, 306-317 (2011).
5. Seoud, M. et al. Cervical adenocarcinoma: moving towards better prevention. Vaccine29, 9148-9158 (2011).
6. International Agency for Research in Cancer. IARC monograph on the evaluation of carcinogenic risk to humans, 64: human papillomaviruses. Lyon, France: IARC Scientific publications, (1995).
7. Clavel, C. et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br. J. Cancer84, 1616-1623 (2001).
8. Manos, M. M. et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cell7, 209-214 (1989).
9. De Roda Husman, A. M. et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76, 1057-1062 (1995).
10. Hubbard, R. A. Human papillomavirus testing methods. Arch. Pathol. Lab. Med. 127, 940-945 (2003).
11. Qu, W. et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer system. J. Clin. Microbiol. 35, 1304-1310 (1997).
12. Brooks, D. E. et al. RAMP(TM): A rapid, quantitative whole blood immunochromatographic platform for point-of-care testing. Clin. Chem. 45, 1676-1678 (1999).
13. Ahn, J. S. et al. Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood. Clin. Chim. Acta332, 51-59 (2003).
14. Bertazzoni, G. et al. Lack of evidence for an association between seminoma and human papillomavirus infection using GP5+/GP6+ consensus primers. J. Med. Virol. 85, 105-109 (2013).
15. Sambrook, J. et al. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 6. 23-6. 27 (2001).
16. Kim, B. C. et al. Simplified laser fluorescence scanner for proteomics studies and early cancer diagnosis. Proc. SPIE4916, 103-108 (2002).